DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities
Background Prolonged use of anticholinergic and sedative medicines is correlated with
worsening cognition and physical function decline. Deprescribing is a proposed intervention …
worsening cognition and physical function decline. Deprescribing is a proposed intervention …
[引用][C] DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities
N Ailabouni, D Mangin… - International Journal of …, 2019 - espace.library.uq.edu.au
Background Prolonged use of anticholinergic and sedative medicines is correlated with
worsening cognition and physical function decline. Deprescribing is a proposed intervention …
worsening cognition and physical function decline. Deprescribing is a proposed intervention …
DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities.
N Ailabouni, D Mangin, PS Nishtala - International Journal of …, 2019 - europepmc.org
Background Prolonged use of anticholinergic and sedative medicines is correlated with
worsening cognition and physical function decline. Deprescribing is a proposed intervention …
worsening cognition and physical function decline. Deprescribing is a proposed intervention …
DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities
N Ailabouni, D Mangin… - International journal of …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Prolonged use of anticholinergic and sedative medicines is correlated with
worsening cognition and physical function decline. Deprescribing is a proposed intervention …
worsening cognition and physical function decline. Deprescribing is a proposed intervention …
DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities
N Ailabouni, D Mangin… - International Journal of …, 2019 - researchportal.bath.ac.uk
Background Prolonged use of anticholinergic and sedative medicines is correlated with
worsening cognition and physical function decline. Deprescribing is a proposed intervention …
worsening cognition and physical function decline. Deprescribing is a proposed intervention …
DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities
N Ailabouni, D Mangin, PS Nishtala - International Journal of Clinical …, 2019 - Springer
Background Prolonged use of anticholinergic and sedative medicines is correlated with
worsening cognition and physical function decline. Deprescribing is a proposed intervention …
worsening cognition and physical function decline. Deprescribing is a proposed intervention …
[PDF][PDF] DEFEAT-polypharmacy: Deprescribing anticholinergic and sedative medicines Feasibility Trial in Residential Aged Care Facilities 2
N Ailabouni, N Ailabouni - core.ac.uk
Prescribing medicines is practiced routinely and is often driven by test results, symptoms or
a confirmed 6 disease diagnosis [1], with some prescribers considering continuing …
a confirmed 6 disease diagnosis [1], with some prescribers considering continuing …
DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities
N Ailabouni, D Mangin… - International Journal of …, 2019 - search.proquest.com
Background Prolonged use of anticholinergic and sedative medicines is correlated with
worsening cognition and physical function decline. Deprescribing is a proposed intervention …
worsening cognition and physical function decline. Deprescribing is a proposed intervention …